Suppr超能文献

根治性子宫切除术和系统淋巴结清扫术后高危宫颈癌的辅助化疗与同期放化疗比较。

Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.

机构信息

The Division of Gynecology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumicho, Suntogun, Shizuoka, 411-8777, Japan.

出版信息

Int J Clin Oncol. 2016 Aug;21(4):741-747. doi: 10.1007/s10147-016-0955-3. Epub 2016 Feb 8.

Abstract

BACKGROUND

The aims of this study were to evaluate the efficacy and toxicity of chemotherapy (CT) compared with concurrent chemoradiotherapy (CCRT) after radical hysterectomy and lymphadenectomy in high-risk patients with early-stage cervical cancer and to evaluate whether the radicality of the lymphadenectomy would affect the outcome and toxicity of postoperative adjuvant therapy.

METHODS

The cases of all patients (n = 393) with FIGO IB1-IIB cervical cancer who were treated by radical surgery at Shizuoka Cancer Center between January 2002 and December 2013 were reviewed. Of these, 111 patients met the inclusion criteria for this retrospective study: (1) high risk for occurrence due to pathologically confirmed parametrial invasion and/or pelvic lymph node metastasis; (2) postoperative treatment with adjuvant CT or CCRT. The clinical data of these patients were reviewed.

RESULTS

Of the 111 patients, 37 and 74 patients underwent CT and CCRT, respectively. The 4-year progression-free survival rate [PFS; 71.7 (CT) vs. 68.3 % (CCRT)] and overall survival rate [76.0 (CT) vs. 82.7 % (CCRT)] did not differ significantly between the two groups. The CT group contained significantly more patients with severe neutropenia than the CCRT group (66.7 vs. 23.0 %, respectively; p < 0.001), and the CCRT group contained significantly more patients with diarrhea than the CT group (10.8 vs. 0 %, respectively; p = 0.04). The patients who had ≥40 lymph nodes dissected (≥40 group) had higher PFS than the patients who had <40 lymph nodes dissected (<40 group) (73.2 vs. 64.2 %, respectively), although the difference was not significant. In the CT group, there was no significant association between the number of dissected lymph nodes and severe toxicities. However, in the CCRT group, significantly more vomiting (p = 0.046) and edema (p = 0.046) occurred in the ≥40 group than in the <40 group.

CONCLUSIONS

Chemotherapy after surgery for high-risk patients had similar efficacy and a different toxicity profile compared with CCRT, and a more radical surgical procedure would improve the survival outcome. However, CCRT was associated with worse toxicity than CT. We advocate a prospective randomized study to compare CT with CCRT for patients with high-risk factors for recurrence.

摘要

背景

本研究旨在评估根治性子宫切除术和淋巴结清扫术后高危早期宫颈癌患者接受化疗(CT)与同期放化疗(CCRT)的疗效和毒性,并评估淋巴结清扫术的彻底性是否会影响术后辅助治疗的结果和毒性。

方法

回顾分析 2002 年 1 月至 2013 年 12 月在静冈癌症中心接受根治性手术的所有 FIGO IB1-IIB 宫颈癌患者(n=393)的病例。其中,111 例患者符合本回顾性研究的纳入标准:(1)由于病理证实的宫旁浸润和/或盆腔淋巴结转移而存在高复发风险;(2)术后接受辅助 CT 或 CCRT 治疗。回顾分析这些患者的临床资料。

结果

111 例患者中,37 例接受 CT 治疗,74 例接受 CCRT 治疗。两组 4 年无进展生存率[PFS;71.7%(CT)与 68.3%(CCRT)]和总生存率[76.0%(CT)与 82.7%(CCRT)]无显著差异。CT 组中性粒细胞减少症严重程度明显高于 CCRT 组(分别为 66.7%与 23.0%;p<0.001),CCRT 组腹泻发生率明显高于 CT 组(分别为 10.8%与 0%;p=0.04)。清扫≥40 个淋巴结的患者(≥40 组)的 PFS 高于清扫<40 个淋巴结的患者(<40 组)(分别为 73.2%与 64.2%),但差异无统计学意义。在 CT 组中,淋巴结清扫数量与严重毒性之间无显著相关性。然而,在 CCRT 组中,清扫≥40 个淋巴结的患者中,呕吐(p=0.046)和水肿(p=0.046)的发生率明显高于清扫<40 个淋巴结的患者。

结论

与 CCRT 相比,高危患者术后化疗的疗效相似,但毒性谱不同,更彻底的手术可提高生存结局。然而,CCRT 的毒性比 CT 更严重。我们提倡开展前瞻性随机研究,比较 CT 与 CCRT 治疗有复发高危因素的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验